384 related articles for article (PubMed ID: 32616237)
1. Generation and evaluation of a vaccine candidate of attenuated and heat-resistant genotype VIII Newcastle disease virus.
Ruan B; Liu Q; Chen Y; Niu X; Wang X; Zhang C; Guo M; Zhang X; Cao Y; Wu Y
Poult Sci; 2020 Jul; 99(7):3437-3444. PubMed ID: 32616237
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
[TBL] [Abstract][Full Text] [Related]
3. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
[TBL] [Abstract][Full Text] [Related]
4. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
[TBL] [Abstract][Full Text] [Related]
5. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
[TBL] [Abstract][Full Text] [Related]
6. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens.
Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q
Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533
[TBL] [Abstract][Full Text] [Related]
7. Construction of Novel Thermostable Chimeric Vaccine Candidates for Genotype VII Newcastle Disease Virus.
Cao Y; Bo Z; Ruan B; Guo M; Zhang C; Zhang X; Wu Y
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680122
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
[TBL] [Abstract][Full Text] [Related]
9. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a thermostable Newcastle disease virus strain TS09-C as an in-ovo vaccine for chickens.
Wen G; Li L; Yu Q; Wang H; Luo Q; Zhang T; Zhang R; Zhang W; Shao H
PLoS One; 2017; 12(2):e0172812. PubMed ID: 28234989
[TBL] [Abstract][Full Text] [Related]
12. Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs.
Hu Z; Hu S; Meng C; Wang X; Zhu J; Liu X
Avian Dis; 2011 Sep; 55(3):391-7. PubMed ID: 22017036
[TBL] [Abstract][Full Text] [Related]
13. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
[TBL] [Abstract][Full Text] [Related]
14. A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding.
Xu X; Ding Z; Yuan Q; Ding J; Li J; Wang W; Cong Y; Ouyang W; Wang Y; Qian J; Yin R
Vaccine; 2019 Jan; 37(3):444-451. PubMed ID: 30545716
[TBL] [Abstract][Full Text] [Related]
15. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
Manoharan VK; Varghese BP; Paldurai A; Samal SK
PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
[TBL] [Abstract][Full Text] [Related]
16. Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
Liu H; de Almeida RS; Gil P; Majó N; Nofrarías M; Briand FX; Jestin V; Albina E
Vaccine; 2018 Jun; 36(27):3917-3925. PubMed ID: 29843999
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX.
Liu M; Shen X; Li J; Yu Y; Fan J; Jia X; Dai Y
Vet Immunol Immunopathol; 2023 May; 259():110591. PubMed ID: 37030151
[TBL] [Abstract][Full Text] [Related]
18. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
[TBL] [Abstract][Full Text] [Related]
20. Recombinant-attenuated
Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
